1 / 3

North American Prazosin Market Size, Share, Analysis, Industry Report and Forecast to 2026

North American prazosin market is estimated to decline at a CAGR of around -1.9% during the forecast period. Moreover, the discontinuation of prazosin drug manufacturing by various companies also showcases the low opportunity in the market. In the US, Pfizer has discontinued Minipress XL, Minizide, and only marketing Minipress. Other companies including Watson Labs, Ani Pharms Inc., Dava Pharms Inc., Purepac Pharm has already discontinued the manufacturing of prazosin hydrochloride in the US market. Lower sales of the branded drug are also restraining the growth of the market.

larebomrglobal
Download Presentation

North American Prazosin Market Size, Share, Analysis, Industry Report and Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research North American Prazosin Market:Industry Growth, Size, Share and Forecast 2020-2026 Request a Free Sample of Report North American Prazosin Market https://www.omrglobal.com/request- sample/north-american-prazosin-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040

  2. North American prazosin market is estimated to decline at a CAGR of around -1.9% during the forecast period. Moreover, the discontinuation of prazosin drug manufacturing by various companies also showcases the low opportunity in the market. In the US, Pfizer has discontinued Minipress XL, Minizide, and only marketing Minipress. Other companies including Watson Labs, Ani Pharms Inc., Dava Pharms Inc., Purepac Pharm has already discontinued the manufacturing of prazosin hydrochloride in the US market. Lower sales of the branded drug are also restraining the growth of the market. As per ClinCalc LLC (an online medical resource tool website), the prescription of prazosin in the US was increased to 2.4 million in 2016 from around 1.0 million in 2014. After 2016, the number of prescriptions of prazosin is expected to decrease continuously in the near future. A full Report of North American Prazosin Market at https://www.omrglobal.com/industry-reports/north- american-prazosin-market The report is intended for prazosin market players, potential entrants, and pharmaceutical companies for the overall market and competitive analysis. The report provides an in-depth analysis on market size, products offered by the market players, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions. The Report Covers Comprehensive research methodology of the North American Prazosin Market. This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting North American Prazosin Market. Insights about market determinants which are stimulating the North American Prazosin Market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/north-american-prazosin-market Japan Prazosin Market Segmentation By Application Cardiovascular Disease( CVD) Neurological Syndromes Prostate Disorders Kidney Disorders

  3. Company Profiles Ajinomoto Co., Inc. Johnlee Pharmaceuticals Pvt. Ltd. Merck KGaA Pfizer Inc. R&D Systems Inc. Renata Ltd. Mylan N.V. Standard Chem and Pharmaceuticals Co. Ltd. Sun Pharmaceuticals Industries Ltd. Teva Pharmaceuticals Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/north-american-prazosin-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related